Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Evvy Launches Science-Backed Treatments for Vaginal Symptom Relief

Evvy Logo (PRNewsfoto/Evvy)

News provided by

Evvy

Nov 14, 2024, 09:00 ET

Share this article

Share toX

Share this article

Share toX

The new prescription product line provides fast-acting relief for common vaginal symptoms like dryness, odor, and pH imbalance — furthering Evvy's mission to increase access to effective, science-backed vaginal healthcare.

NEW YORK, Nov. 14, 2024 /PRNewswire/ -- Evvy, a female-founded vaginal microbiome startup, today unveiled new prescription grade, at-home treatments that provide clean, fast-acting vaginal symptom relief. This marks the first time patients can access prescription (Rx) products from Evvy without first taking an Evvy vaginal microbiome test, a significant step forward in their mission to expand access to effective, science-backed women's healthcare.

The new Rx product line includes Pure Boric Acid Suppositories, Hyaluronic Acid Suppositories, Anti-Itch Vulva Cream, and Soothing Vulva Cream — all uniquely formulated by leading OBGYNs and expert vaginal microbiome researchers to address common vaginal health concerns. Patients can order the treatments on Evvy's website, at which point they are matched to an Evvy-affiliated provider who reviews their health information and can prescribe Evvy's Rx products.

To address common symptoms like vaginal pH imbalance, dryness, odor, or irritation, Evvy's at-home treatments are clean, prescription-grade, and non-toxic solutions compounded in a 503a NABP-accredited pharmacy with the highest-quality ingredients. They are designed to alleviate symptoms while users await the comprehensive results of their Evvy Vaginal Health Test.

"Vaginal discomfort remains a leading reason women and people with vaginas seek medical advice, yet patients lack access to high-quality, effective solutions," says Dr. Kate McLean, Evvy's Chief Medical Officer. "Our Vaginal Health Test has already helped tens of thousands of patients pinpoint and treat the root cause of their vaginal symptoms. With this launch, we're expanding access to our science-backed symptom relief treatments to provide a comprehensive approach that delivers both immediate relief and long-term results."

Each product is made with carefully selected, high quality ingredients, and is free from PFAs, parabens, BPAs, phthalates, sulfites, artificial dyes, and fragrances — setting a new standard for clean and effective vaginal healthcare.

  • Pure Boric Acid Suppositories ($35): A pure, fragrance-free vaginal suppository designed to balance vaginal pH and reduce symptoms like vaginal odor and discomfort.
  • Hyaluronic Acid Suppositories ($59): A hormone-free, deeply moisturizing vaginal suppository designed to provide relief for vaginal dryness and pain with sex.
  • Anti-Itch Vulva Cream ($59):– A fast-acting topical cream formulated with hydrocortisone, aloe, and vitamin E, designed to soothe external itching and inflammation.
  • Soothing Vulva Cream ($59): A gentle topical cream enriched with hyaluronic acid, aloe, and vitamin E, designed to provide relief for external dryness and irritation.

While these new treatments offer fast-acting symptom relief, Evvy's Vaginal Health Test remains the most advanced tool for identifying the root cause of vaginal symptoms and guiding patients to the most effective, targeted treatments to rebuild their vaginal microbiome. The Evvy Vaginal Health Test is the world's first and only peer-reviewed, CLIA/CAP/CLEP-certified at-home vaginal microbiome test. It tests for 700+ bacteria and fungi with a single swab (including those related to bacterial vaginosis, yeast infections, UTIs, fertility, and more).

"Our new prescription product line will empower patients to manage their symptoms quickly and confidently while Evvy's advanced testing gets to the root cause of their symptoms," explains Priyanka Jain, co-founder and CEO of Evvy, "Once patients receive results from our world-leading vaginal microbiome test, we can go beyond symptom relief to deliver personalized care that supports long-term microbiome health for each patient."

Patients who take the Vaginal Health Test also gain access to personalized treatment programs that can include a broader range of Evvy's specialized prescription treatments, including targeted antibiotics, antifungals, vaginal estrogen, and vaginal probiotics — going beyond symptom relief to fight infections and rebuild a healthy vaginal microbiome.

The launch of this prescription product line reflects Evvy's mission to revolutionize vaginal health with science-backed, personalized care — a constant commitment in the face of access to women's healthcare being at risk nationwide. By empowering patients to manage symptoms quickly and effectively, Evvy makes it easier for individuals to discreetly take charge of their health while also providing tools to uncover and address the root causes of symptoms. With advanced testing and treatments tailored to each person's unique microbiome, Evvy is setting a new standard in precision care. Evvy's Vaginal Health Test is available in all 50 states, while Evvy's new treatments are available in 39 states with plans to expand in 2025. For more information about Evvy's new symptom relief treatments, the Vaginal Health Test, and our clinical care platform, visit www.evvy.com.

About Evvy:
Evvy is closing the gender health gap by leveraging overlooked female biomarkers, starting with the vaginal microbiome. The Evvy Vaginal Health Test is the world's first peer-reviewed and CLIA/CAP/CLEP-certified at-home vaginal microbiome test, leveraging metagenomic sequencing to test for 700+ bacteria and fungi with a single swab (including those related to bacterial vaginosis, yeast infections, recurrent UTIs, and much more). Evvy's larger vaginal healthcare platform is the first to combine state-of-the-art vaginal microbiome and STI testing, precision clinical care, and coaching to give women and people with vaginas the care they deserve. Through this platform, Evvy has built the world's largest and most comprehensive dataset on the vaginal microbiome, and is leveraging their platform to improve outcomes across infertility, preterm birth, gynecological cancers, and more.

SOURCE Evvy

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Evvy Announces the Company's First Chief Medical Officer and Publishes Peer-Reviewed Validation on the Evvy Vaginal Health Test, Advancing its Mission of Unlocking Precision Female Healthcare

Evvy Announces the Company's First Chief Medical Officer and Publishes Peer-Reviewed Validation on the Evvy Vaginal Health Test, Advancing its Mission of Unlocking Precision Female Healthcare

Evvy, a female-founded biotech startup, announces significant milestones in driving the future of precision female healthcare: Evvy appoints industry ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

New Products & Services

New Products & Services

Women

Women

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.